Clinical trial
A Longitudinal Observational Cohort Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
NCT02724735 is registered in ClinicalTrials.gov with Neuralstem Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Longitudinal Observational Cohort Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
- Lead sponsor
- Neuralstem Inc.
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 31, 2016
- Completion date
- January 31, 2018
- Enrollment
- 220 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.